Fig. 2.
Complementarity determining region III (CDR III) from MCL patients undergoing BMT. VH, D, and JH regions and N-inserts from the CDR III are shown. Location of allele specific oligonucleotide (ASO) primers are shown in bold. VH, D region (where it could be identified) and JH usage for each patient is noted.